vs
Donnelley Financial Solutions, Inc.（DFIN）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Donnelley Financial Solutions, Inc.的1.3倍（$219.9M vs $172.5M），Donnelley Financial Solutions, Inc.净利率更高（3.6% vs -1.0%，领先4.6%），Donnelley Financial Solutions, Inc.同比增速更快（10.4% vs 2.0%），Donnelley Financial Solutions, Inc.自由现金流更多（$47.9M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -7.9%）
唐nelley金融解决方案（DFIN）是一家总部位于美国伊利诺伊州芝加哥市的金融合规企业，面向资本市场与投资市场的各类企业，提供符合美国监管要求的软件即服务产品、软件赋能服务、印刷业务及合规相关服务，助力客户满足合规要求。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
DFIN vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.3倍
$172.5M
营收增速更快
DFIN
高出8.4%
2.0%
净利率更高
DFIN
高出4.6%
-1.0%
自由现金流更多
DFIN
多$31.1M
$16.8M
两年增速更快
OFIX
近两年复合增速
-7.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $172.5M | $219.9M |
| 净利润 | $6.2M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 8.3% | 0.2% |
| 净利率 | 3.6% | -1.0% |
| 营收同比 | 10.4% | 2.0% |
| 净利润同比 | -1.6% | 92.4% |
| 每股收益（稀释后） | $0.31 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DFINOFIX
| Q4 25 | $172.5M | $219.9M | ||
| Q3 25 | $175.3M | $205.6M | ||
| Q2 25 | $218.1M | $203.1M | ||
| Q1 25 | $201.1M | $193.6M | ||
| Q4 24 | $156.3M | $215.7M | ||
| Q3 24 | $179.5M | $196.6M | ||
| Q2 24 | $242.7M | $198.6M | ||
| Q1 24 | $203.4M | $188.6M |
净利润DFINOFIX
| Q4 25 | $6.2M | $-2.2M | ||
| Q3 25 | $-40.9M | $-22.8M | ||
| Q2 25 | $36.1M | $-14.1M | ||
| Q1 25 | $31.0M | $-53.1M | ||
| Q4 24 | $6.3M | $-29.1M | ||
| Q3 24 | $8.7M | $-27.4M | ||
| Q2 24 | $44.1M | $-33.4M | ||
| Q1 24 | $33.3M | $-36.0M |
毛利率DFINOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率DFINOFIX
| Q4 25 | 8.3% | 0.2% | ||
| Q3 25 | 16.1% | -8.3% | ||
| Q2 25 | 24.2% | -7.9% | ||
| Q1 25 | 22.8% | -25.2% | ||
| Q4 24 | 6.0% | -5.3% | ||
| Q3 24 | 10.1% | -9.6% | ||
| Q2 24 | 26.6% | -12.5% | ||
| Q1 24 | 21.9% | -15.6% |
净利率DFINOFIX
| Q4 25 | 3.6% | -1.0% | ||
| Q3 25 | -23.3% | -11.1% | ||
| Q2 25 | 16.6% | -6.9% | ||
| Q1 25 | 15.4% | -27.4% | ||
| Q4 24 | 4.0% | -13.5% | ||
| Q3 24 | 4.8% | -13.9% | ||
| Q2 24 | 18.2% | -16.8% | ||
| Q1 24 | 16.4% | -19.1% |
每股收益（稀释后）DFINOFIX
| Q4 25 | $0.31 | $-0.05 | ||
| Q3 25 | $-1.49 | $-0.57 | ||
| Q2 25 | $1.28 | $-0.36 | ||
| Q1 25 | $1.05 | $-1.35 | ||
| Q4 24 | $0.21 | $-0.76 | ||
| Q3 24 | $0.29 | $-0.71 | ||
| Q2 24 | $1.47 | $-0.88 | ||
| Q1 24 | $1.09 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.5M | $82.0M |
| 总债务越低越好 | $171.3M | — |
| 股东权益账面价值 | $379.2M | $450.0M |
| 总资产 | $800.4M | $850.6M |
| 负债/权益比越低杠杆越低 | 0.45× | — |
8季度趋势，按日历期对齐
现金及短期投资DFINOFIX
| Q4 25 | $24.5M | $82.0M | ||
| Q3 25 | $22.7M | $62.9M | ||
| Q2 25 | $33.8M | $65.6M | ||
| Q1 25 | $16.2M | $58.0M | ||
| Q4 24 | $57.3M | $83.2M | ||
| Q3 24 | $33.6M | $30.1M | ||
| Q2 24 | $35.0M | $26.4M | ||
| Q1 24 | $43.7M | $27.0M |
总债务DFINOFIX
| Q4 25 | $171.3M | — | ||
| Q3 25 | $154.7M | $157.2M | ||
| Q2 25 | $190.1M | $157.0M | ||
| Q1 25 | $189.5M | $156.9M | ||
| Q4 24 | $124.7M | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益DFINOFIX
| Q4 25 | $379.2M | $450.0M | ||
| Q3 25 | $423.1M | $442.5M | ||
| Q2 25 | $432.1M | $458.3M | ||
| Q1 25 | $419.9M | $458.3M | ||
| Q4 24 | $436.1M | $503.1M | ||
| Q3 24 | $444.5M | $525.9M | ||
| Q2 24 | $441.5M | $546.0M | ||
| Q1 24 | $408.9M | $570.3M |
总资产DFINOFIX
| Q4 25 | $800.4M | $850.6M | ||
| Q3 25 | $816.3M | $832.6M | ||
| Q2 25 | $874.7M | $837.2M | ||
| Q1 25 | $852.8M | $823.1M | ||
| Q4 24 | $841.6M | $893.3M | ||
| Q3 24 | $843.6M | $867.9M | ||
| Q2 24 | $882.9M | $882.0M | ||
| Q1 24 | $867.8M | $906.0M |
负债/权益比DFINOFIX
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.37× | 0.36× | ||
| Q2 25 | 0.44× | 0.34× | ||
| Q1 25 | 0.45× | 0.34× | ||
| Q4 24 | 0.29× | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $59.8M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $47.9M | $16.8M |
| 自由现金流率自由现金流/营收 | 27.8% | 7.6% |
| 资本支出强度资本支出/营收 | 6.9% | 4.9% |
| 现金转化率经营现金流/净利润 | 9.65× | — |
| 过去12个月自由现金流最近4个季度 | $107.8M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流DFINOFIX
| Q4 25 | $59.8M | $27.7M | ||
| Q3 25 | $74.4M | $12.4M | ||
| Q2 25 | $68.4M | $11.6M | ||
| Q1 25 | $-37.7M | $-18.4M | ||
| Q4 24 | $56.4M | $23.7M | ||
| Q3 24 | $86.4M | $11.7M | ||
| Q2 24 | $56.2M | $9.0M | ||
| Q1 24 | $-27.9M | $-18.6M |
自由现金流DFINOFIX
| Q4 25 | $47.9M | $16.8M | ||
| Q3 25 | $59.2M | $2.5M | ||
| Q2 25 | $51.7M | $4.5M | ||
| Q1 25 | $-51.0M | $-25.1M | ||
| Q4 24 | $41.3M | $15.2M | ||
| Q3 24 | $67.3M | $6.3M | ||
| Q2 24 | $36.8M | $-360.0K | ||
| Q1 24 | $-40.2M | $-29.1M |
自由现金流率DFINOFIX
| Q4 25 | 27.8% | 7.6% | ||
| Q3 25 | 33.8% | 1.2% | ||
| Q2 25 | 23.7% | 2.2% | ||
| Q1 25 | -25.4% | -13.0% | ||
| Q4 24 | 26.4% | 7.0% | ||
| Q3 24 | 37.5% | 3.2% | ||
| Q2 24 | 15.2% | -0.2% | ||
| Q1 24 | -19.8% | -15.4% |
资本支出强度DFINOFIX
| Q4 25 | 6.9% | 4.9% | ||
| Q3 25 | 8.7% | 4.8% | ||
| Q2 25 | 7.7% | 3.5% | ||
| Q1 25 | 6.6% | 3.5% | ||
| Q4 24 | 9.7% | 4.0% | ||
| Q3 24 | 10.6% | 2.7% | ||
| Q2 24 | 8.0% | 4.7% | ||
| Q1 24 | 6.0% | 5.6% |
现金转化率DFINOFIX
| Q4 25 | 9.65× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.89× | — | ||
| Q1 25 | -1.22× | — | ||
| Q4 24 | 8.95× | — | ||
| Q3 24 | 9.93× | — | ||
| Q2 24 | 1.27× | — | ||
| Q1 24 | -0.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DFIN
| Technology Service | $68.0M | 39% |
| Capital Markets Compliance And Communications Management | $61.6M | 36% |
| Investment Companies Software Solutions | $30.9M | 18% |
| Print And Distribution Service | $13.6M | 8% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
